MMS | Jotup

VITAMIN ANGELS EXPANDED US REACH BY 25% AND PACKAGE OF NUTRITION SOLUTIONS, FURTHERING MISSION TO END MALNUTRITION WORLDWIDE

Retrieved on:

Monday, January 22, 2024

GOLETA, Calif., Jan. 22, 2024 /PRNewswire/ -- As the United States' maternal health crisis continues, Vitamin Angels focused its efforts on expanding its US programs, increasing its reach by 25% over the last five years and providing thousands of underserved pregnant women in the US with the prenatal vitamins and minerals they need to support a healthy pregnancy. Additionally, the organization strengthened healthcare systems globally and expanded its package of nutrition solutions, piloting research and programs focused on breastfeeding and complementary feeding support. By year's end, Vitamin Angels reached over 71 million nutritionally vulnerable pregnant women, infants, and young children with proven nutrition solutions in every state in the US and in about 65 countries around the world.

Key Points:

Additionally, the organization strengthened healthcare systems globally and expanded its package of nutrition solutions, piloting research and programs focused on breastfeeding and complementary feeding support.
By year's end, Vitamin Angels reached over 71 million nutritionally vulnerable pregnant women, infants, and young children with proven nutrition solutions in every state in the US and in about 65 countries around the world.
"We made incredible progress this past year towards our mission to improve maternal and child nutrition worldwide," said Howard Schiffer, Vitamin Angels Founder and President.
In an effort to address this need, Vitamin Angels plans to reach 50% of underserved pregnant women in the US with prenatal vitamins and minerals by the end of 2024.

Maximus Declares Quarterly Cash Dividend of $0.30 per Share

Retrieved on:

Thursday, January 11, 2024

Public Policy, Government, Other Professional Services, Software, Consulting, Data Management, Professional Services, Technology, MMS

Maximus (NYSE: MMS), a leading provider of government services worldwide, announced today that its Board of Directors has approved a quarterly cash dividend of $0.30 per share, payable on February 29, 2024, to shareholders of record on February 15, 2024.

Key Points:

Maximus (NYSE: MMS), a leading provider of government services worldwide, announced today that its Board of Directors has approved a quarterly cash dividend of $0.30 per share, payable on February 29, 2024, to shareholders of record on February 15, 2024.

Maximus Schedules Fiscal 2024 First Quarter Conference Call

Retrieved on:

Monday, January 8, 2024

Professional Services, Data Management, Public Policy, Government, Technology, Software, Consulting, Webcast, MMS, Broadcasting

Maximus (NYSE: MMS), a leading provider of government services worldwide, will issue a press release with its financial results for the three months ended December 31, 2023, after market close on Wednesday, February 7, and will host a conference call the following day at 9:00 a.m.

Key Points:

Maximus (NYSE: MMS), a leading provider of government services worldwide, will issue a press release with its financial results for the three months ended December 31, 2023, after market close on Wednesday, February 7, and will host a conference call the following day at 9:00 a.m.
ET on Thursday, February 8.
Shareholders are invited to submit questions for management’s consideration by emailing [email protected] up to one hour prior to the call.
The call is open to the public and available by webcast or by phone at:
For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com .

Maximus Awarded $32 Million IRS Data Delivery Services (DDS) Task Order

Retrieved on:

Thursday, January 4, 2024

Technology, Accounting, Public Policy, Government, Professional Services, Software, Networks, White House, Federal Government, Data Analytics, Data Management, IRS, DDS, IDIQ, Internal Revenue Service, MMS, Average revenue per user

Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced it has been awarded a four-year, $32 million Data Delivery Services (DDS) contract with the Internal Revenue Service (IRS), through the Alliant 2 IDIQ.

Key Points:

Maximus (NYSE: MMS), a leading employer and provider of government services worldwide, today announced it has been awarded a four-year, $32 million Data Delivery Services (DDS) contract with the Internal Revenue Service (IRS), through the Alliant 2 IDIQ.
Maximus will provide development support to two mission-critical systems at the IRS.
Additionally, Maximus will consult with the agency on the design, build, and deployment of world-class data services to internal and external IRS stakeholders while refining and evolving the IRS Enterprise Data solution.
The company will provide continuous, high-availability services that will operate, sustain, and manage these databases in support of the overall DDS Data Strategy.

Maximus DE&I Efforts Recognized in Third-Party Racial Equity Audit

Retrieved on:

Friday, December 22, 2023

In September 2022, Maximus announced it engaged WilmerHale to perform a racial equity audit.

Key Points:

In September 2022, Maximus announced it engaged WilmerHale to perform a racial equity audit.
As part of the audit, WilmerHale assessed the company’s operations, policies, ongoing DE&I efforts, and public engagement through a racial equity lens.
The audit built upon Maximus’ DE&I initiatives and commitment to racial equity and justice for all employees.
“We are proud that WilmerHale’s racial equity audit recognizes our efforts to date and appreciate their thoughtful recommendations to continue promoting DE&I at Maximus.

Brevo Launches MMS Capabilities Ahead of Holiday Shopping Season

Retrieved on:

Monday, November 13, 2023

Communication, MMS, Multimedia Messaging Service, Generation Z, Multimedia, Freedom, Gen, CRM, WhatsApp, SMS, Mobile phone

SEATTLE, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Brevo , a leading provider of Customer Relationship Management (CRM) solutions, today announced the launch of Multimedia Messaging Service (MMS) for its US customers.

Key Points:

SEATTLE, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Brevo , a leading provider of Customer Relationship Management (CRM) solutions, today announced the launch of Multimedia Messaging Service (MMS) for its US customers.
With Brevo’s new MMS capabilities, users can now add a single image up to 850 KB alongside 1,600 characters of text*.
As small businesses prepare for the competitive holiday shopping season, creating differentiated touchpoints with prospective buyers will be key to standing out amongst competitors.
“With the freedom to choose from MMS, SMS, email, WhatsApp, phone and video meetings, Brevo customers can select the right channel for each interaction.”
*Each MMS charge will be equivalent to 2.1 SMS credits.

MMS Supported MAPS Public Benefit Corporation NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD

Retrieved on:

Wednesday, December 13, 2023

MMS, a data-focused Clinical Research Organization (CRO), announced MAPS Public Benefit Corporation (MAPS PBC) submitted a New Drug Application (NDA) to the FDA for MDMA (midomafetamine capsules) used in combination with psychological intervention, which includes psychotherapy, or talk therapy, and other supportive services provided by a qualified healthcare provider.

Key Points:

MMS, a data-focused Clinical Research Organization (CRO), announced MAPS Public Benefit Corporation (MAPS PBC) submitted a New Drug Application (NDA) to the FDA for MDMA (midomafetamine capsules) used in combination with psychological intervention, which includes psychotherapy, or talk therapy, and other supportive services provided by a qualified healthcare provider.
MAPS PBC is developing investigational MDMA-assisted therapy for individuals with post-traumatic stress disorder (PTSD).
Over a year ago, MAPS PBC selected MMS as its CRO partner for the development of NDA for MDMA-assisted therapy for PTSD.
We are grateful to MAPS PBC for entrusting MMS to be a part of this process.”
As MAPS PBC’s CRO, MMS provided regulatory strategy and operations, pharmacovigilance, medical writing, and biometrics services.

Consumers Shop More on Black Friday But Businesses Earn More on Cyber Monday, Bloomreach Peak Holiday Shopping Results Find

Retrieved on:

Tuesday, December 5, 2023

We’re pleased to have been there to support our customers through another incredible peak shopping season, with 100% uptime and no disruptions to service.

Key Points:

We’re pleased to have been there to support our customers through another incredible peak shopping season, with 100% uptime and no disruptions to service.
We look forward to seeing how they’ll top these results next year.”
Cyber Week 2023 Results and Trends:
Shopping starts earlier.
Bloomreach customers saw a 7% increase YoY in site traffic on Thanksgiving day, proving that consumers did not need to wait for Black Friday to start their shopping.
To learn more about consumer trends and e-commerce performance throughout the year, join Bloomreach for its quarterly Commerce Pulse events.

Study Finds Nurse Practitioners and Physician Assistants Would Alter Patient Care Decisions Based on DecisionDx®-Melanoma Test Results

Retrieved on:

Friday, December 1, 2023

The study found that more than 90% of the NPs/PAs who completed a survey about DecisionDx-Melanoma believe that prognostic (i.e., risk-stratification) information about a patient’s melanoma is valuable and improves patient care.

Key Points:

The study found that more than 90% of the NPs/PAs who completed a survey about DecisionDx-Melanoma believe that prognostic (i.e., risk-stratification) information about a patient’s melanoma is valuable and improves patient care.
Of the 369 NPs/PAs who completed the survey, 176 (47.7%) reported using the DecisionDx-Melanoma test in the prior 12 months.
90.5% of the respondents felt that comprehensive prognostic testing, such as with DecisionDx-Melanoma, improves patient care.
Most (62.1%) reported that a high-risk DecisionDx-Melanoma test result would alter their treatment plan for a patient with a thin tumor (≤1mm).

Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2023

Retrieved on:

Wednesday, November 15, 2023

Highlights for the fourth quarter and full fiscal year 2023 include:

Key Points:

Highlights for the fourth quarter and full fiscal year 2023 include:
Full year revenue increased 5.9% to $4.90 billion, compared to $4.63 billion for the prior year.
Excluding the previously disclosed cybersecurity incident, adjusted earnings per share were $4.18 and $1.38 for the full year and fourth quarter, respectively, of fiscal year 2023.
Revenue for the fourth quarter of fiscal year grew 7.0% to $1.26 billion, or 7.4% on an organic basis.
Adjusted diluted earnings excluding the incident were $4.18 and $1.38 per share for the full year and fourth quarter, respectively, of fiscal year 2023.